◼ Archived
Business
Updated: Electra says $350M IPO will help it become a commercial biotech
Immunology drugmaker Electra Therapeutics pursues an upsized $350 million initial public offering on Nasdaq under the ticker ETRA.
1 trends tracked about this subject — the full history, oldest to newest below.
Immunology drugmaker Electra Therapeutics pursues an upsized $350 million initial public offering on Nasdaq under the ticker ETRA.